XOMA

About:

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation

Website: http://www.xoma.com

Twitter/X: xomacorp

Top Investors: Blue Owl, Novartis

Description:

XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation today. Building on a pioneering proprietary pipeline, a world-class antibody discovery and development platform, plus multiple revenue streams, XOMA is creating innovative human antibody therapeutics with the potential to transform medicine and reshape people's lives.

Total Funding Amount:

$296M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Berkeley, California, United States

Founded Date:

1981-01-01

Contact Email:

BizDevInfo(AT)xoma.com

Founders:

Patrick J. Scannon

Number of Employees:

51-100

Last Funding Date:

2023-12-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai